Drug shortages in developed countries—reasons, therapeutic consequences, and handling Susie DillJin Ahn Review Article 18 September 2014 Pages: 1405 - 1412
Statins, mood, sleep, and physical function: a systematic review Kristopher J. SwigerRaoul J. ManalacSeth S. Martin Review Article 08 October 2014 Pages: 1413 - 1422
Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature Maria KellySuzanne McCarthyLaura Jane Sahm Review Article 04 October 2014 Pages: 1423 - 1431
Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients Błażej MisiakDorota FrydeckaAndrzej Kiejna Pharmacodynamics Open access 08 October 2014 Pages: 1433 - 1441
Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts Meral Urhan KüçükNehir SucuBahar Tunçtan Pharmacogenetics 27 September 2014 Pages: 1443 - 1451
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer Therese EricssonAntje BlankAngela Äbelö Pharmacokinetics and Disposition 25 September 2014 Pages: 1453 - 1463
Adjustment of endogenous concentrations in pharmacokinetic modeling Alexander BauerMartin J. Wolfsegger Pharmacokinetics and Disposition 03 October 2014 Pages: 1465 - 1470
Clozapine serum concentrations in dopamimetic psychosis in Parkinson’s disease and related disorders Ulrich C. LutzAhmad SirfyAnil Batra Pharmacokinetics and Disposition 18 October 2014 Pages: 1471 - 1476
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA2DS2VASc scores: experience from the Stockholm region Tomas ForslundBjörn WettermarkPaul Hjemdahl Pharmacoepidemiology and Prescription 16 September 2014 Pages: 1477 - 1485
Electrocardiographic monitoring for new prescriptions of quetiapine co-prescribed with acetylcholinesterase inhibitors or memantine from 2005 to 2009. A population study on community-dwelling older people in Italy Claudio BilottaCarlotta FranchiCarlo Vergani Pharmacoepidemiology and Prescription 20 September 2014 Pages: 1487 - 1494
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry L. PasinaA. L. BrucatoREPOSI Investigators Pharmacoepidemiology and Prescription 18 September 2014 Pages: 1495 - 1503
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions C. BiagiV. ContiD. Motola Pharmacoepidemiology and Prescription 20 September 2014 Pages: 1505 - 1512
Reported ingested dose of paracetamol as a predictor of risk following paracetamol overdose Y. LeangD. M. TaylorS. L. Greene Pharmacoepidemiology and Prescription 01 October 2014 Pages: 1513 - 1518
Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital G. DurrieuA. BatzJ. L. Montastruc Pharmacoepidemiology and Prescription 12 October 2014 Pages: 1519 - 1526
Practical application of statistical models aimed at assessing bioequivalence through network meta-analysis Andrea Messori Letter to the Editors 18 September 2014 Pages: 1527 - 1528
Establishing the correlation between statins and cough: case series report and analysis of adverse drug reactions in the international databases Carla CarnovalePaolo PellegrinoSonia Radice Letter to the Editors 24 September 2014 Pages: 1529 - 1531